Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd., established in 1970, having over 13,000 employees globally, is the largest manufacturer of antineoplastics in China. Its operating income was over USD 1.7 billion in 2016. The company stock was officially listed on the Shanghai Stock Exchange in 2000. All APIs and finish dosage forms have passed national GMP authentication. For APIs, we got approvals from US-FDA, EDQM, PMDA and TGA. For FDFs, we got approvals from US-FDA, EU and PMDA.
Location: 

Contact details

No.7, Kunlunshan Road,
Economic & Technological Development Zone
222047
Lianyungang
Jiangsu
China